Research.Patient.info
Acute graft versus host disease (aGvHD) research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingTherapeutic exploratory (Phase II)
Phase 2 Open Label Prospective Dose-Ranging Clinical Trial with Escalation and Expansion Cohorts to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Dosing, and Efficacy of RLS-0071 for the Treatment of Hospitalized Patients with Steroid -Refractory Acute Graft-versus-Host Disease
This study is testing a new drug, RLS-0071, for hospital patients with a serious condition called acute graft-versus-host disease (aGvHD) that hasn't responded to usual steroid treatment. We want to see if it's safe, how well it works, and find the best dose.
Germany · Spain - ongoing, recruitingTherapeutic exploratory (Phase II)
A randomized, single-blind trial to evaluate the safety and efficacy of apraglutide in subjects with Grade II to IV (MAGIC) steroid refractory gastrointestinal (GI) acute graft versus host disease on best available therapy.
This study looks at a new drug, apraglutide, for people with a serious gut problem called acute graft versus host disease (aGVHD) that hasn't responded to usual steroid treatment. We want to see how safe it is and if it helps improve their condition.
Germany